References
- Cohen AL, Wenger JB, James-Todd T, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014;33(1):81–92.
- ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American college of obstetricians and gynecologists. Int J Gynaecol Obstet. 2002;77:67–75.
- Ringholm L, Damm JA, Vestgaard M, et al. Diabetic nephropathy in women with preexisting diabetes: from pregnancy planning to breastfeeding. Curr Diab Rep. 2016;16(2):12.
- Mathiesen ER, Ringholm L, Feldt-Rasmussen B, et al. Obstetric nephrology: pregnancy in women with diabetic nephropathy – the role of antihypertensive treatment. Clin J Am Soc Nephrol. 2012;7(12):2081–2088.
- Davison JM, Noble MCB. Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. BJOG. 1981;88(1):10–17.
- Feldman AZ, Brown FM. Management of type 1 diabetes in pregnancy. Curr Diab Rep. 2016;16:76.
- Reader D, et al. Medical nutrition therapy: goals for pregnancy complicated by pre-existing diabetes mellitus. In: Kitzmiller JL, Jovanovic LB, Brown FM, editors. Manag. preexisting diabetes pregnancy tech. Rev. Consens. Recomm. Alexandria: ADA; 2008.
- Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008;2(6):1094–1100.
- Akaza M, Akaza I, Kanouchi T, et al. Nerve conduction study of the association between glycemic variability and diabetes neuropathy. Diabetol Metab Syndr. 2018;10:69.
- Dalfrà MG, Sartore G, Cianni GD, et al. Glucose variability in diabetic pregnancy. Diabetes Technol Ther. 2011;13(8):853–859.
- Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–1603.
- American Diabetes Association. 7. Diabetes technology: Standards of medical care in diabetes—2019. Diabetes Care. 2019;42:S71–S80.
- Feig DS, Murphy HR. Continuous glucose monitoring in pregnant women with type 1 diabetes: benefits for mothers, using pumps or pens, and their babies. Diabet Med. 2018;35(4):430–435.
- Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:CD002252. doi:10.1002/14651858.CD002252.pub4
- Howarth C, Gazis A, James D. Associations of type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med. 2007;24(11):1229–1234.
- Jensen DM, Damm P, Ovesen P, et al. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care. 2010;33(1):90–94.
- Varughese GI, Chowdhury SR, Warner DP, et al. Preconception care of women attending adult general diabetes clinics—are we doing enough? Diabetes Res Clin Pract. 2007;76(1):142–145.
- NICE. National institute for health and care excellence (2015). Diabetes in pregnancy: management from preconception to the postnatal period. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 16. PMID: 32212588.
- Gáborová M, Doničová V, Bačová I, et al. Glycaemic variability and risk factors of pregnant women with and without gestational diabetes mellitus measured by continuous glucose monitoring. IJERPH. 2021;18(7):3402.
- Ringholm L, Damm P, Mathiesen ER. Improving pregnancy outcomes in women with diabetes mellitus: modern management. Nat Rev Endocrinol. 2019;15(7):406–416.
- Yu W, Wu N, Li L, et al. A review of research progress on glycemic variability and gestational diabetes. Diabetes Metab Syndr Obes. 2020;13:2729–2741.